Detalhe da pesquisa
1.
Perspectives on the Clinical Development of NRF2-Targeting Drugs.
Handb Exp Pharmacol
; 264: 93-141, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32776282
2.
Inhibition of glycogen synthase kinase-3 enhances NRF2 protein stability, nuclear localisation and target gene transcription in pancreatic beta cells.
Redox Biol
; 71: 103117, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38479223
3.
Specific targeting of the NRF2/ß-TrCP axis promotes beneficial effects in NASH.
Redox Biol
; 69: 103027, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38184999
4.
Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.
Redox Biol
; 67: 102881, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37696195
5.
The current status and future prospects for therapeutic targeting of KEAP1-NRF2 and ß-TrCP-NRF2 interactions in cancer chemoresistance.
Free Radic Biol Med
; 192: 246-260, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36181972
6.
An inhibitor of interaction between the transcription factor NRF2 and the E3 ubiquitin ligase adapter ß-TrCP delivers anti-inflammatory responses in mouse liver.
Redox Biol
; 55: 102396, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839629
7.
Can Activation of NRF2 Be a Strategy against COVID-19?
Trends Pharmacol Sci
; 41(9): 598-610, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32711925
8.
Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas.
Redox Biol
; 30: 101425, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31918259
9.
Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties.
Eur J Med Chem
; 190: 112090, 2020 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32018096
10.
Activators and Inhibitors of NRF2: A Review of Their Potential for Clinical Development.
Oxid Med Cell Longev
; 2019: 9372182, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31396308
11.
Corrigendum to "An inhibitor of interaction between the transcription factor NRF2 and the E3 ubiquitin ligase adapter ß-TrCP delivers anti-inflammatory responses in mouse liver" [Redox Biol. 55 (2022) 102396/PMID: 35839629].
Redox Biol
; 55: 102428, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35931641